Table 3.
Odds Ratios of Antiplatelet Adherence (≥80%) with Percutaneous Coronary Intervention cohort, 2017–2019.
| Household income | Model 1a |
Model 2b |
Model 3c |
|||
|---|---|---|---|---|---|---|
| OR (95% CI) | p-value | OR (95% CI) | p-value | OR (95% CI) | p-value | |
| <$40k | 1.66 (1.59, 1.74) | <.0001 | 1.50 (1.43, 1.57) | <.0001 | 1.48 (1.40, 1.56) | <.0001 |
| $40k-<$50k | 1.56 (1.46, 1.66) | <.0001 | 1.45 (1.36, 1.54) | <.0001 | 1.432 (1.33, 1.52) | <.0001 |
| $50k-<$60k | 1.36 (1.28, 1.45) | <.0001 | 1.28 (1.20, 1.36) | <.0001 | 1.25 (1.17, 1.34) | <.0001 |
| $60k-<$75k | 1.25 (1.18, 1.33) | <.0001 | 1.19 (1.12, 1.26) | <.0001 | 1.17 (1.10, 1.24) | <.0001 |
| $75k-<$100k | 1.19 (1.13, 1.26) | <.0001 | 1.15 (1.09, 1.22) | <.0001 | 1.14 (1.08, 1.21) | <.0001 |
| $100k+ | Referent | Referent | Referent | |||
a
Model 1 – adjusted for age, sex, race.
b
Model 2 – adjusted for age sex, race, Elixhauser covariates, prior MI, PCI, or CABG.
c
Model 3 – adjusted for adjusted for age sex, race, Elixhauser covariates, prior MI, PCI, or CABG, educational attainment, insurance type, follow-up visits with cardiologist, polypharmacy, co-pay, and antiplatelet type.